Study to Evaluate Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1)
Clinical trial NCT00989612 · COMPLETED
Trial details
- NCT number
- NCT00989612
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-10-01
- Primary completion
- 2010-04-19
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.